Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Sanfelippo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Pathology|September 19, 2009
Automated assay for fondaparinux (Arixtra) on the Dade Behring BCS XPMichael J Sanfelippo, Veronica B Tillema
Archives of Pathology & Laboratory Medicine|July 1, 2014
Antithrombin levels are unaffected by warfarin useMichael J Sanfelippo, Jessica M Engel, Adedayo A Onitilo
Clinical Laboratory|February 6, 2015
Symptomatic factor XIII deficiency with normal urea solubility testMichael J Sanfelippo, Joseph J Mazza, Richard J Mercier
Clinical Medicine & Research|July 24, 2009
Use of chromogenic assay of factor X to accept or reject INR results in Warfarin treated patientsMichael J Sanfelippo, Wendy Zinsmaster, Doris L Scherr, et al.
Thrombosis|December 6, 2012
Anti-phospholipid antibodies in patients undergoing total joint replacement surgeryMelissa Simpson, Michael J Sanfelippo, Adedayo A Onitilo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Pathology|September 19, 2009
Automated assay for fondaparinux (Arixtra) on the Dade Behring BCS XPMichael J Sanfelippo, Veronica B Tillema
Archives of Pathology & Laboratory Medicine|July 1, 2014
Antithrombin levels are unaffected by warfarin useMichael J Sanfelippo, Jessica M Engel, Adedayo A Onitilo
Clinical Laboratory|February 6, 2015
Symptomatic factor XIII deficiency with normal urea solubility testMichael J Sanfelippo, Joseph J Mazza, Richard J Mercier
Clinical Medicine & Research|July 24, 2009
Use of chromogenic assay of factor X to accept or reject INR results in Warfarin treated patientsMichael J Sanfelippo, Wendy Zinsmaster, Doris L Scherr, et al.
Thrombosis|December 6, 2012
Anti-phospholipid antibodies in patients undergoing total joint replacement surgeryMelissa Simpson, Michael J Sanfelippo, Adedayo A Onitilo, et al.
Pageof 1